| Unichem Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506690 |
NSE Symbol : UNICHEMLAB |
P/E(TTM) : - |
|
ISIN Demat : INE351A01035 |
Div & Yield% : - |
EPS(TTM) : 0.37 |
|
Book Value(₹) : 325.91 |
Market Cap(₹Cr) : 4,511.25 |
Face Value(₹) : 2.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 1,442.17 | 1,072.43 | 942.93 | 1,123.97 | 904.44 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 1,442.17 | 1,072.43 | 942.93 | 1,123.97 | 904.44 |
| Other Income | 98.40 | 41.85 | 42.07 | 47.37 | 99.17 |
| Stock Adjustments | 26.36 | -22.01 | 52.79 | 16.73 | 18.50 |
| Total Income | 1,566.93 | 1,092.27 | 1,037.79 | 1,188.07 | 1,022.11 |
| EXPENDITURE : | |||||
| Raw Materials | 717.83 | 501.86 | 436.27 | 449.67 | 401.25 |
| Power and Fuel Cost | 105.64 | 101.41 | 77.12 | 67.95 | 72.14 |
| Other Manufacturing Expenses | 74.62 | 70.61 | 73.49 | 64.48 | 68.09 |
| Selling and Administration Expenses | 236.37 | 194.89 | 192.65 | 225.80 | 263.43 |
| Miscellaneous Expenses | 125.62 | 116.36 | 8.95 | 3.28 | 3.48 |
| Employee Benefit Expenses | 283.14 | 270.86 | 250.79 | 234.04 | 205.16 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 23.70 | -163.73 | -1.49 | 142.84 | 8.56 |
| Interest | 10.42 | 9.38 | 2.07 | 1.30 | 1.28 |
| Gross Profit | 13.28 | -173.11 | -3.56 | 141.54 | 7.28 |
| Depreciation | 105.46 | 105.98 | 83.19 | 75.89 | 71.09 |
| Profit Before Tax | -92.18 | -279.09 | -86.75 | 65.65 | -63.81 |
| Current Tax | - | - | - | - | - |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | - | 20.61 | -31.32 | 11.56 | -7.50 |
| Reported Net Profit | -92.18 | -299.70 | -55.43 | 54.08 | -56.32 |
| Extraordinary Items | -55.94 | -103.16 | -0.25 | 0.02 | -1.45 |
| Adjusted Net Profit | -36.24 | -196.54 | -55.18 | 54.06 | -54.87 |
| Adjustment below Net Profit | - | 121.81 | - | - | - |
| Profit/Loss Balance carried down | 2,359.31 | 2,565.36 | 2,648.96 | 2,623.04 | 2,712.21 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | -12.05 | 28.16 | 28.16 | 28.16 | 32.85 |
| P & L Balance carried down | 2,279.18 | 2,359.31 | 2,565.36 | 2,648.96 | 2,623.04 |
| Dividend | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | - | 200.00 | 200.00 | 200.00 | 200.00 |
| Dividend Per Share(Rs) | - | 4.00 | 4.00 | 4.00 | 4.00 |
| Earnings Per Share-Unit Curr | -13.09 | -42.57 | -7.87 | 7.68 | -8.00 |
| Earnings Per Share(Adj)-Unit Curr | -13.09 | -42.57 | -7.87 | 7.68 | -8.00 |
| Book Value | 325.91 | 338.65 | 379.52 | 383.11 | 375.99 |
| Book Value(Adj)-Unit Curr | 325.91 | 338.65 | 379.52 | 383.11 | 375.99 |